SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Savara Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$4.63+0.18 (+4.04%)
Close on Oct 19, 2026
- Market cap
- $1.17B
- P/E (TTM)
- –
- Dividend yield
- –
Savara statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Savara | Industry median |
|---|---|---|
| Market Cap | $951.28M | $166.30M |
| Enterprise Value | $808.36M | $88.19M |
| PB Ratio | 6.62 | 2.03 |
| P/TBV Ratio | 6.62 | 2.29 |
Income (trailing twelve months)
| Measure | Savara | Industry median |
|---|---|---|
| Operating Income | -$143.63M | -$21.40M |
| Net Income | -$139.31M | -$22.46M |
| EBITDA | -$143.55M | -$16.91M |
| EPS (Diluted) | -$0.58 | -$0.83 |
Returns
| Measure | Savara | Industry median |
|---|---|---|
| Return on Equity (ROE) | -105.5% | -53.2% |
| Return on Assets (ROA) | -78.3% | -40.9% |
| Return on Invested Capital (ROIC) | -5123.8% | -32.4% |
| Return on Capital Employed (ROCE) | -82.3% | -38.1% |
Balance sheet
| Measure | Savara | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $173.03M | $61.43M |
| Total Debt | $30.11M | $118.52M |
| Net Cash (Debt) | $142.93M | $15.35M |
| Net Cash Per Share | $0.70 | $0.66 |
| Equity (Book Value) | $143.66M | $49.09M |
| Book Value Per Share | $0.70 | $1.37 |
| Tangible Book Value | $143.66M | $23.52M |
| Working Capital | $160.72M | $76.81M |
Financial position
| Measure | Savara | Industry median |
|---|---|---|
| Current Ratio | 10.13 | 3.34 |
| Quick Ratio | 9.83 | 2.44 |
| Debt / Equity | 0.21 | 0.52 |
Cash flow (trailing twelve months)
| Measure | Savara | Industry median |
|---|---|---|
| Operating Cash Flow | -$110.38M | -$12.35M |
| Capital Expenditures | -$280.00K | -$1.08M |
| Free Cash Flow | -$110.66M | -$20.22M |
| FCF Per Share | -$0.54 | -$0.42 |
Efficiency
| Measure | Savara | Industry median |
|---|---|---|
| Profits Per Employee | -$1.99M | -$703.34K |
| Employee Count | 70 | 74 |
Dividends and yields
| Measure | Savara | Industry median |
|---|---|---|
| Earnings Yield | -14.6% | -23.3% |
| FCF Yield | -11.6% | -8.72% |
Shares
| Measure | Savara | Industry median |
|---|---|---|
| Shares Outstanding | 205,460,000 | 58,127,000 |
| Shares Change (YoY) | 12.1% | 10.9% |
| Shares Change (QoQ) | 0.23% | 0.54% |
| Float | 156,235,000 | 49,136,700 |
| Shares Held by Insiders | 24.0% | 11.6% |
| Shares Held by Institutions | 109.1% | 59.4% |
Scores
| Measure | Savara | Industry median |
|---|---|---|
| Altman Z-Score | 5.32 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Savara's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.